NaNotics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 10

NaNotics General Information

Description

Developer of a nanomedical platform designed for treating major diseases by removing specific molecules from the bloodstream. The company's platform uses nanoparticles injected like a drug to quickly and safely target and deplete disease-causing molecules within minutes, enabling physicians to offer patients a new and safe treatment modality.

Contact Information

Website
nanotics.com
Formerly Known As
Ntercept
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 100 Shoreline Highway
  • Suite B100
  • Mill Valley, CA 94941
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • 100 Shoreline Highway
  • Suite B100
  • Mill Valley, CA 94941
  • United States

NaNotics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NaNotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Accelerator/Incubator 25-Sep-2024 Completed Pre-Clinical Trials
7. Later Stage VC 01-Apr-2024 Completed Pre-Clinical Trials
6. Later Stage VC 11-Aug-2023 Completed Pre-Clinical Trials
5. Later Stage VC (Series B) Cancelled Pre-Clinical Trials
4. Later Stage VC 09-Nov-2022 Completed Pre-Clinical Trials
3. Early Stage VC (Series A2) 01-Jun-2018 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 01-Jul-2016 $6M $6.5M Completed Startup
1. Seed Round 15-Nov-2015 $500K $500K Completed Startup
To view NaNotics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NaNotics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nanomedical platform designed for treating major diseases by removing specific molecules from the bloodst
Drug Discovery
Mill Valley, CA
7 As of 2025

Zurich, Switzerland
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NaNotics Competitors (2)

One of NaNotics’s 2 competitors is Hemotune, a Venture Capital-Backed company based in Zurich, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Hemotune Venture Capital-Backed Zurich, Switzerland
Immunicom Venture Capital-Backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

NaNotics Patents

  • 55

    Total Documents Applications and Grants

  • Total Patents Families

  • 29

    Granted

  • 14

    Pending

  • Expiring in next 12 mo

NaNotics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026039820-A1 Methods of treating neurodegenerative diseases Pending 16-Aug-2024
JP-2023075293-A Method for assembling entrapped particles Pending 04-Jan-2017
EP-3565604-A1 Methods for assembling scavenging particles Inactive 04-Jan-2017
EP-3565604-A4 Methods for assembling scavenging particles Inactive 04-Jan-2017
US-11065345-B2 Methods for assembling scavenging particles Active 04-Jan-2017 A61K47/6929
To view NaNotics’s complete patent history, request access »

NaNotics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NaNotics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
H&S Ventures Venture Capital Minority
Melnichek Investments Venture Capital Minority
Meltwind Advisory Venture Capital Minority
Summit Harbor Holdings Corporation Minority
LifeSpan Vision Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

NaNotics FAQs

  • When was NaNotics founded?

    NaNotics was founded in 2015.

  • Where is NaNotics headquartered?

    NaNotics is headquartered in Mill Valley, CA.

  • What is the size of NaNotics?

    NaNotics has 7 total employees.

  • What industry is NaNotics in?

    NaNotics’s primary industry is Drug Discovery.

  • Is NaNotics a private or public company?

    NaNotics is a Private company.

  • What is NaNotics’s current revenue?

    The current revenue for NaNotics is .

  • How much funding has NaNotics raised over time?

    NaNotics has raised $31M.

  • Who are NaNotics’s investors?

    H&S Ventures, Melnichek Investments, Meltwind Advisory, Summit Harbor Holdings, and LifeSpan Vision Ventures are 5 of 10 investors who have invested in NaNotics.

  • Who are NaNotics’s competitors?

    Hemotune and Immunicom are competitors of NaNotics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process